Seres Therapeutics
Elizabeth Halvorsen has an extensive background in microbiology, with experience working at various prestigious institutions and companies. Elizabeth has held positions ranging from Scientist I to Director in companies like Seres Therapeutics and Cubist Pharmaceuticals. Elizabeth's research focuses on infection prevention systems against pathogens, utilizing innovative assays to evaluate efficacy and safety of technology. Elizabeth has also conducted research on the role of specific proteins in infection models, as well as characterizing protein-protein interactions. Elizabeth holds a Ph.D. in Microbiology from the University of Illinois Urbana-Champaign and a Bachelor of Science in Biotechnology from Rutgers University.
This person is not in any teams
Seres Therapeutics
5 followers
Seres Therapeutics is developing revolutionary microbiome-based therapeutics to treat serious diseases.